Progressive hypoxia-on-a-chip: An in vitro oxygen gradient model for capturing the effects of hypoxia on primary hepatocytes in health and disease.

Autor: Kang YBA; Department of Surgery, Center for Engineering in Medicine, Harvard Medical School, Massachusetts General Hospital, Shriners Hospitals for Children-Boston, Boston, Massachusetts.; Department of Mechanical & Civil & Biomedical Engineering, College of Engineering, George Fox University, Newberg, Oregon., Eo J; Department of Surgery, Center for Engineering in Medicine, Harvard Medical School, Massachusetts General Hospital, Shriners Hospitals for Children-Boston, Boston, Massachusetts., Bulutoglu B; Department of Surgery, Center for Engineering in Medicine, Harvard Medical School, Massachusetts General Hospital, Shriners Hospitals for Children-Boston, Boston, Massachusetts., Yarmush ML; Department of Surgery, Center for Engineering in Medicine, Harvard Medical School, Massachusetts General Hospital, Shriners Hospitals for Children-Boston, Boston, Massachusetts.; Department of Biomedical Engineering, Rutgers University, Piscataway, New Jersey., Usta OB; Department of Surgery, Center for Engineering in Medicine, Harvard Medical School, Massachusetts General Hospital, Shriners Hospitals for Children-Boston, Boston, Massachusetts.
Jazyk: angličtina
Zdroj: Biotechnology and bioengineering [Biotechnol Bioeng] 2020 Mar; Vol. 117 (3), pp. 763-775. Date of Electronic Publication: 2019 Nov 28.
DOI: 10.1002/bit.27225
Abstrakt: Oxygen is vital to the function of all tissues including the liver and lack of oxygen, that is, hypoxia can result in both acute and chronic injuries to the liver in vivo and ex vivo. Furthermore, a permanent oxygen gradient is naturally present along the liver sinusoid, which plays a role in the metabolic zonation and the pathophysiology of liver diseases. Accordingly, here, we introduce an in vitro microfluidic platform capable of actively creating a series of oxygen concentrations on a single continuous microtissue, ranging from normoxia to severe hypoxia. This range approximately captures both the physiologically relevant oxygen gradient generated from the portal vein to the central vein in the liver, and the severe hypoxia occurring in ischemia and liver diseases. Primary rat hepatocytes cultured in this microfluidic platform were exposed to an oxygen gradient of 0.3-6.9%. The establishment of an ascending hypoxia gradient in hepatocytes was confirmed in response to the decreasing oxygen supply. The hepatocyte viability in this platform decreased to approximately 80% along the hypoxia gradient. Simultaneously, a progressive increase in accumulation of reactive oxygen species and expression of hypoxia-inducible factor 1α was observed with increasing hypoxia. These results demonstrate the induction of distinct metabolic and genetic responses in hepatocytes upon exposure to an oxygen (/hypoxia) gradient. This progressive hypoxia-on-a-chip platform can be used to study the role of oxygen and hypoxia-associated molecules in modeling healthy and injured liver tissues. Its use can be further expanded to the study of other hypoxic tissues such as tumors as well as the investigation of drug toxicity and efficacy under oxygen-limited conditions.
(© 2019 Wiley Periodicals, Inc.)
Databáze: MEDLINE
Externí odkaz: